HOME >> BIOLOGY >> NEWS
Calcium and Lead: should you worry?

For years, women have been urged to take calcium supplements to prevent osteoporosis. Now a new study uncovers detectable levels of lead in some of the leading supplements. Whats a woman to do? According to the January issue of Mayo Clinic Womens HealthSource, most of these levels are not high enough to cause significant harm, so women should keep taking their supplements.

The study, published in the Sept. 20 issue of the Journal of the American Medical Association, looked at 21 widely available calcium supplements, including seven natural, oyster shell products. Of those seven, four (Spring Valley, Nature Made, Os-Cal and Eckerd) had up to two micrograms of lead in each dose. Thats well below the absolute maximum daily intake of lead, which is six micrograms.

Of the 14 refined calcium supplements listed, four of the remaining 14 brands (Caltrate, Eckerd, Advanced Nutritional Technology and R and D Laboratories) had up to three micrograms of lead per 1,500 milligram dose of calcium, still lower than the six microgram max.

Although no lead intake is definitely the safest, Mayo Clinic doctors believe that these levels are not as harmful as the potential results of a calcium deficiency. Women should keep taking their daily dose of calcium to protect their present and future health.


'"/>

Contact: Shelly Plutowski
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
4-Jan-2001


Page: 1

Related biology news :

1. Calcium supplements associated with decreased risk of large bowel polyps
2. Calcium channels control coronary artery relaxation
3. Calcium channel involved in coronary artery relaxation
4. Calcium signals found to guide nerve cell development
5. Calcium absorption is not affected by a high protein diet
6. Calcium is not as readily absorbed from soy milk as from cows milk
7. Calcium not the only key to bone health in older women
8. Purdue Study: Calcium May Curb Weight Gain In Young Women
9. Trees Need Calcium Too
10. New England Journal Of Medicine Reports Calcium Supplements Help Prevent Polyp Recurrence; DMS Led Study
11. Study: Calcium Supplements Appear To Protect Against Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Calcium and Lead should you worry

(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
(Date:4/16/2015)... 2015 OncoTAb, Inc., ... Charlotte) spin-out company, announced today the appointment of ... as Chief Operating Officer (COO). Cooper brings to ... developing clinical diagnostic and biotechnology platforms in the ... Cooper’s extensive career transcends the field of medical ...
(Date:4/16/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. ... the orphan disorder, neurotrophic keratopathy (NK), and a ... (DES) in the U.S.  Both trials will be ... Each of these eye disorders was being targeted ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: